Provided by Tiger Trade Technology Pte. Ltd.

Autonomix Medical Inc

5.27
0.0000
Post-market: 5.23-0.0400-0.76%19:48 EDT
Volume:109.84K
Turnover:596.62K
Market Cap:5.12M
PE:-0.11
High:5.87
Open:5.19
Low:5.19
Close:5.27
52wk High:32.55
52wk Low:2.44
Shares:971.04K
Float Shares:526.40K
Volume Ratio:0.78
T/O Rate:20.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-46.5038
EPS(LYR):-48.7200
ROE:-315.99%
ROA:-157.81%
PB:1.62
PE(LYR):-0.11

Loading ...

Aug 26, 2025

Major Issues Report

Form 8-K - Current report
Aug 20, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Jul 22, 2025

Major Issues Report

Form 8-K - Current report
May 29, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Mar 11, 2025

Correspondence

Form CORRESP - Correspondence
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 22, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 27, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 25, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Correspondence

Form CORRESP - Correspondence
Nov 20, 2024

Correspondence

Form CORRESP - Correspondence
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]